Sfoglia per Rivista HAEMATOLOGICA
New pharmacologic strategies for arterial and venous thromboembolism
2001 Agnelli, Giancarlo
New reciprocal translocation t(5;10)(q33;q22) associated with atypical chronic myeloid leukemia.
1999 Siena, S.; Sammarelli, G.; Grimoldi, M.; Schiavo, R.; Nozza, A.; Roncalli, M.; Mecucci, Cristina; Santoro, A.; Carlo Stella, C.
Non-B, non-T acute lymphoblastic leukaemia terminating in malignant histiocytosis: a new case and a review of the literature.
1982 Martelli, Massimo Fabrizio; Tabilio, A; Aversa, F; Mecucci, Cristina; Spinozzi, Fabrizio; Venti, G; Falini, B; Rambotti, P.
Non-B, non-T acute lymphoblastic leukaemia terminating in malignant histiocytosis: a new case and a review of the literature.
1982 Martelli, Massimo Fabrizio; Tabilio, Antonio; Aversa, F.; Mecucci, Cristina; Spinozzi, Fabrizio; Venti, G.; Falini, Brunangelo; Rambotti, P.
NOTCH-1 ACTIVATION AND SUBCLONAL MUTATION NEGATIVELY IMPACT ON CHRONIC LYMPHOCYTIC LEUKEMIA OUTCOMES
2020 Baldoni, S; Del Papa, B; Dorillo, E; De Falco, F; Rompietti, C; Adamo, Fm; Cecchini, D; Mondani, E; Zei, T; Fabi, B; Cantelmi, Mg; Guarente, V; Di Ianni, M; Rosati, E; Sportoletti, P
A NOVEL MECHANISM FOR NOTCH1 ACTIVATIONIN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS: INVOLVEMENT OF NOTCH1 ENDOSOMAL TRAFFICKING AND ALTERATIONS IN RAB PROTEINS
2020 Del Papa, B; De Falco, F; Baldoni, S; Dorillo, E; Rompietti, C; Adamo, F; Scialdone, Ar; Guarente, V; Di Ianni, M; Mondani, E; Cecchini, D; Cantelmi, Mg; Ostini, Ri; Rosati, E; Sportoletti, P
NPM1 AND FLT3-ITD MUTATIONS SINERGISTICALLY INDUCE GATA1 EPIGENETIC SILENCING IN A AML MOUSE MODEL
2016 Sportoletti, Paolo; Varasano, Emanuela; Celani, Letizia; Rossi, Roberta; Rompietti, Chiara; Strozzini, Francesca; DEL PAPA, Beatrice; Cecchini, Debora; Bereshchenko, Oxana; Haferlach, T.; Martelli, Maria Paola; Falzetti, Franca; Falini, Brunangelo
NPM1 gene mutations in acute myeloid leukemia.
2005 Rosati, R; Gorello, P; Bonasso, R; LA STARZA, Roberta; Roti, Giovanni; Cazzaniga, G; Crescenzi, B; Biondi, A; Lo Coco, F; Pession, A; Diverio, D; Martelli, Mf; Falini, B; Mecucci, Cristina
NPM1 haploinsufficiency in MDS/AML with del(5q)/monosomy 5
2007 Starza, R. L.; Roti, Giovanni; L., Brandimarte; E., Varasano; F., Arcioni; Pierini, Antonio; B., Crescenzi; D., Diverio; G., Guglielmini; M. F., Martelli; A., Aventin; Mecucci, Cristina
NPM1 mutations and cytoplasmic nucleophosmin are mutually exclusive of recurrent genetic abnormalities: a comparative analysis of 2562 patients with acute myeloid leukemia.
2008 Falini, Brunangelo; Mecucci, Cristina; Saglio, G.; Lo Coco, F.; Diverio, D.; Brown, P.; Pane, F.; Mancini, M.; Martelli, Maria Paola; Pileri, S.; Haferlach, C.; Haferlach, T.; Schnittger, S.
OAT with POC devices and remote computer monitoring in the setting of the Italian NHS: a controlled clinical trial
2004 Paccamiccio, E.; Ferrante, F.; Trottini, S.; Rosafalco, M.; Duca, E.; Vecchioli, M.; Nenci, Giuseppe Giorgio; Iorio, Alfonso
On the potential involvement of CD11d in co-stimulating the production of interferon-gamma by natural killer cells upon interaction with neutrophils via intercellular adhesion molecule-3
2011 Costantini, C; Micheletti, A; Calzetti, F; Perbellini, O; Tamassia, N; Albanesi, C; Vermi, W; Cassatella, Ma
Oral Melphalan, Prednisone and Thalidomide In Elderly Multiple Myeloma Patients: Updated Results of A Randomized Controlled Trial
2008 A., Palumbo; S., Bringhen; Liberati, Anna Marina; T., Caravita; A., Falcone; V., Callea; C., Cangialosi; M., Grasso; M., Galli; F., Rossini; L., Catalano; V. D., Stefano; S., Morandi; M. T., Petrucci; P., Falco; A., Larocca; V., Magarotto; G., Ciccone; M., Cavo; M., Boccadoro
Oral melphalan, prednisone,thalidomide versus oral melphalan, prednisone in elderly newly diagnosed myeloma patients
2007 A., Palumbo; S., Bringhen; T., Caravita; A., Falcone; V., Callea; C., Cangialosi; M., Grasso; M., Galli; F., Rossini; L., Catalano; M., Montanaro; V. D., Stefano; V., Magarotto; I., Avonto; P., Musto; Liberati, Anna Marina; M., Cavo; M., Boccadoro
Partial duplication of the MLL oncogene in patients with aggressive aute myeloid leukemia
2004 Sambani, C.; LA STARZA, Roberta; Roumier, C.; Crescenzi, Barbara; Stavropoulou, C.; Katsarou, O.; Karafoulidou, A.; Dhalle, J. H.; Lai, J.; Preudhomme, C.; Martelli, Massimo Fabrizio; Mecucci, Cristina
Pathologist's point of view (I): indolent lymphomas.
2000 Pileri, S. A.; Ascani, Stefano; Sabattini, E.; Fraternali Orcioni, G.; Poggi, S.; Piccioli, M.; Piccaluga, P. P.; Gamberi, B.; Zinzani, P. L.; Leoncini, L.; Falini, B.
The pathologist's view point. Part II --aggressive lymphomas
2000 Pileri, S.; Ascani, Stefano; Sabattini, E.; Fraternali Orcioni, G.; Poggi, S.; Piccioli, M.; Piccalunga, P.; Gamberi, B.; Zinzani, P.; Leoncini, L.; Falini, Brunangelo
Persistence of chromosomal abnormalities additional to the Philadelphia chromosome after Philadelphia chromosome disappearance during imatinib therapy for chronic myeloid leukemia.
2007 Zaccaria, A.; Valenti, A.; Donti, Emilio; Gozzetti, A.; Ronconi, S.; Spedicato, F.
Perspectives on antithrombotic agents: from unfractionated heparin to new antithrombotics
2002 Agnelli, Giancarlo; Sonaglia, F.
Pharmacoeconomic evaluation of the management of oral anticoagulant treatment with point-of-care devices in the Italian national health care system
2004 Iorio, Alfonso; Minciotti, A.; Ferrante, F.; Nenci, Giuseppe Giorgio
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
New pharmacologic strategies for arterial and venous thromboembolism | 2001 | Agnelli, Giancarlo | |
New reciprocal translocation t(5;10)(q33;q22) associated with atypical chronic myeloid leukemia. | 1999 | Siena, S.; Sammarelli, G.; Grimoldi, M.; Schiavo, R.; Nozza, A.; Roncalli, M.; Mecucci, Cristina; Santoro, A.; Carlo Stella, C. | |
Non-B, non-T acute lymphoblastic leukaemia terminating in malignant histiocytosis: a new case and a review of the literature. | 1982 | Martelli, Massimo Fabrizio; Tabilio, A; Aversa, F; Mecucci, Cristina; Spinozzi, Fabrizio; Venti, G; Falini, B; Rambotti, P. | |
Non-B, non-T acute lymphoblastic leukaemia terminating in malignant histiocytosis: a new case and a review of the literature. | 1982 | Martelli, Massimo Fabrizio; Tabilio, Antonio; Aversa, F.; Mecucci, Cristina; Spinozzi, Fabrizio; Venti, G.; Falini, Brunangelo; Rambotti, P. | |
NOTCH-1 ACTIVATION AND SUBCLONAL MUTATION NEGATIVELY IMPACT ON CHRONIC LYMPHOCYTIC LEUKEMIA OUTCOMES | 2020 | Baldoni, S; Del Papa, B; Dorillo, E; De Falco, F; Rompietti, C; Adamo, Fm; Cecchini, D; Mondani, E; Zei, T; Fabi, B; Cantelmi, Mg; Guarente, V; Di Ianni, M; Rosati, E; Sportoletti, P | |
A NOVEL MECHANISM FOR NOTCH1 ACTIVATIONIN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS: INVOLVEMENT OF NOTCH1 ENDOSOMAL TRAFFICKING AND ALTERATIONS IN RAB PROTEINS | 2020 | Del Papa, B; De Falco, F; Baldoni, S; Dorillo, E; Rompietti, C; Adamo, F; Scialdone, Ar; Guarente, V; Di Ianni, M; Mondani, E; Cecchini, D; Cantelmi, Mg; Ostini, Ri; Rosati, E; Sportoletti, P | |
NPM1 AND FLT3-ITD MUTATIONS SINERGISTICALLY INDUCE GATA1 EPIGENETIC SILENCING IN A AML MOUSE MODEL | 2016 | Sportoletti, Paolo; Varasano, Emanuela; Celani, Letizia; Rossi, Roberta; Rompietti, Chiara; Strozzini, Francesca; DEL PAPA, Beatrice; Cecchini, Debora; Bereshchenko, Oxana; Haferlach, T.; Martelli, Maria Paola; Falzetti, Franca; Falini, Brunangelo | |
NPM1 gene mutations in acute myeloid leukemia. | 2005 | Rosati, R; Gorello, P; Bonasso, R; LA STARZA, Roberta; Roti, Giovanni; Cazzaniga, G; Crescenzi, B; Biondi, A; Lo Coco, F; Pession, A; Diverio, D; Martelli, Mf; Falini, B; Mecucci, Cristina | |
NPM1 haploinsufficiency in MDS/AML with del(5q)/monosomy 5 | 2007 | Starza, R. L.; Roti, Giovanni; L., Brandimarte; E., Varasano; F., Arcioni; Pierini, Antonio; B., Crescenzi; D., Diverio; G., Guglielmini; M. F., Martelli; A., Aventin; Mecucci, Cristina | |
NPM1 mutations and cytoplasmic nucleophosmin are mutually exclusive of recurrent genetic abnormalities: a comparative analysis of 2562 patients with acute myeloid leukemia. | 2008 | Falini, Brunangelo; Mecucci, Cristina; Saglio, G.; Lo Coco, F.; Diverio, D.; Brown, P.; Pane, F.; Mancini, M.; Martelli, Maria Paola; Pileri, S.; Haferlach, C.; Haferlach, T.; Schnittger, S. | |
OAT with POC devices and remote computer monitoring in the setting of the Italian NHS: a controlled clinical trial | 2004 | Paccamiccio, E.; Ferrante, F.; Trottini, S.; Rosafalco, M.; Duca, E.; Vecchioli, M.; Nenci, Giuseppe Giorgio; Iorio, Alfonso | |
On the potential involvement of CD11d in co-stimulating the production of interferon-gamma by natural killer cells upon interaction with neutrophils via intercellular adhesion molecule-3 | 2011 | Costantini, C; Micheletti, A; Calzetti, F; Perbellini, O; Tamassia, N; Albanesi, C; Vermi, W; Cassatella, Ma | |
Oral Melphalan, Prednisone and Thalidomide In Elderly Multiple Myeloma Patients: Updated Results of A Randomized Controlled Trial | 2008 | A., Palumbo; S., Bringhen; Liberati, Anna Marina; T., Caravita; A., Falcone; V., Callea; C., Cangialosi; M., Grasso; M., Galli; F., Rossini; L., Catalano; V. D., Stefano; S., Morandi; M. T., Petrucci; P., Falco; A., Larocca; V., Magarotto; G., Ciccone; M., Cavo; M., Boccadoro | |
Oral melphalan, prednisone,thalidomide versus oral melphalan, prednisone in elderly newly diagnosed myeloma patients | 2007 | A., Palumbo; S., Bringhen; T., Caravita; A., Falcone; V., Callea; C., Cangialosi; M., Grasso; M., Galli; F., Rossini; L., Catalano; M., Montanaro; V. D., Stefano; V., Magarotto; I., Avonto; P., Musto; Liberati, Anna Marina; M., Cavo; M., Boccadoro | |
Partial duplication of the MLL oncogene in patients with aggressive aute myeloid leukemia | 2004 | Sambani, C.; LA STARZA, Roberta; Roumier, C.; Crescenzi, Barbara; Stavropoulou, C.; Katsarou, O.; Karafoulidou, A.; Dhalle, J. H.; Lai, J.; Preudhomme, C.; Martelli, Massimo Fabrizio; Mecucci, Cristina | |
Pathologist's point of view (I): indolent lymphomas. | 2000 | Pileri, S. A.; Ascani, Stefano; Sabattini, E.; Fraternali Orcioni, G.; Poggi, S.; Piccioli, M.; Piccaluga, P. P.; Gamberi, B.; Zinzani, P. L.; Leoncini, L.; Falini, B. | |
The pathologist's view point. Part II --aggressive lymphomas | 2000 | Pileri, S.; Ascani, Stefano; Sabattini, E.; Fraternali Orcioni, G.; Poggi, S.; Piccioli, M.; Piccalunga, P.; Gamberi, B.; Zinzani, P.; Leoncini, L.; Falini, Brunangelo | |
Persistence of chromosomal abnormalities additional to the Philadelphia chromosome after Philadelphia chromosome disappearance during imatinib therapy for chronic myeloid leukemia. | 2007 | Zaccaria, A.; Valenti, A.; Donti, Emilio; Gozzetti, A.; Ronconi, S.; Spedicato, F. | |
Perspectives on antithrombotic agents: from unfractionated heparin to new antithrombotics | 2002 | Agnelli, Giancarlo; Sonaglia, F. | |
Pharmacoeconomic evaluation of the management of oral anticoagulant treatment with point-of-care devices in the Italian national health care system | 2004 | Iorio, Alfonso; Minciotti, A.; Ferrante, F.; Nenci, Giuseppe Giorgio |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile